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ABSTRACT
Aminoacylphosphatidylglycerol synthases (aaPGSs) are integral membrane proteins that
use aminoacyl-tRNAs as substrates to catalyze the addition of amino acids to
phosphatidylglycerol (PG) in the cytoplasmic membranes of bacteria. Addition of amino
acids to PG decreases the net negative charge of the membrane, conferring resistance to
various classes of antibacterial agents (i.e., cationic antimicrobial peptides, beta-lactams,
glycopeptides, and lipopeptides) and protecting the cell against osmotic stress and acidic
conditions. aaPGS homologs are found in a variety of clinically relevant microorganisms,
including Enterococcus faecium, which is increasingly found to be the etiologic agent of
antibiotic-resistant nosocomial infections. Although the broad distribution of these
virulence factors across bacterial species makes them attractive targets for therapeutic
strategies, little is known about the structure of aaPGSs. Two aaPGS paralogs are found in E.
faecium, one of which exhibits relaxed substrate specificity and is responsible for the
transfer of Arg (R), Ala (A), and Lys (K) to PG (RakPGS). The catalytic site of RakPGS is
located in the hydrophilic C-terminal domain, which is localized in the cytoplasm. The Nterminus contains an integral membrane domain that is thought to harbor flippase activity
that translocates the neosynthesized aa-PG from the inner to the outer leaflet of the
membrane. We are currently developing the substituted cysteine accessibility method
(SCAM) and a dual-reporter fusion system, which exploits alkaline phosphatase (Pho) and
β-galactosidase (LacZ) activities, for investigating the membrane topology of RakPGS in E.
faecium.
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I. INTRODUCTION
1.1 aaPGSs confer resistance to a wide spectrum of antibacterial agents and stress
conditions
To quickly adapt to ever-changing environmental conditions, bacteria utilize various
mechanisms to adjust the biochemical and biophysical properties of their cellular envelope.
One such mechanism involves the transfer of amino acids (aa) to the membrane lipid
phosphatidylglycerol (PG). This process is catalyzed by aminoacyl-phosphatidylglycerol
synthases (aaPGSs), which use specific aminoacylated tRNAs (aa-tRNAs) as substrates.
Lysinylation and alanylation of PG was discovered in the 1960’s; however, only recently
was a correlation established between this process and a gene called mprF (multiple
peptide resistance factor) [1]. Early investigations of the mprF (i.e., aaPGS) pathway in
Staphylococcus aureus revealed that lysinylation of membrane PG decreases susceptibility
to cationic antimicrobial peptides (CAMPs) produced by the innate immune system of
infected hosts. For example, aaPGS provides S. aureus with resistance to defensins
produced by neutrophils [1]. In addition, aaPGSs in S. aureus have been shown to confer
resistance to other classes of antimicrobial agents including vancomycin (a glycopeptide),
daptomycin (a lipopeptide), and oxacillin (a β-lactam) (Fig 1), (for review see [2]). Recent
studies showed that aaPGSs produce similar effects in a number of clinically relevant
microorganisms, including Mycobacterium tuberculosis [3] and Bacillus anthracis [4].
Modification of membrane lipids by aaPGS also increases the virulence of pathogens in
various cell line and animal models. For example, the aaPGS homolog in Listeria
1

monocytogenes provides an advantage for infection of macrophages and epithelial cells in
mice [5]. Interestingly, the aaPGS homolog in Rhizobium tropici, lpiA, is advantageous for
colonization of plant roots, and its expression is induced by acidic conditions (for review
see, [2]). Increased Lys-PG production in response to acidic conditions has also been
observed in various Staphylococcus, Streptococcus, and Bacillus species, in which it is
thought to decrease membrane permeability to protons [2]. Similarly, Ala-PG confers
resistance to osmotic stress in Pseudomonas aeruginosa [6]. Taken together, these results
have prompted investigation to further define the distribution and activities of aaPGS
homologs.
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aaPGS

Figure 1: aaPGS allows for evasion of cationic antimicrobial peptides, as well as resistance to several classes of
antibiotics and stress conditions. See text for details.
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1.2. Distribution and activities of aaPGS homologs
To date, over 600 sequences of aaPGS homologs have been identified, which are
distributed across 149 bacterial genera that include various human pathogens [7].
Currently, the functions of 23 aaPGS homologs have been characterized, and while most
exhibit specificity for transfer of Lys from Lys-tRNALys to PG, a growing number have been
identified that exhibit different aa-tRNA specificities. For example, the two aaPGS paralogs
found in Clostridium perfringins, LysPGS and AlaPGS, are responsible for transfer of Lys and
Ala to PG, respectively [8]. There are also aaPGS homologs that exhibit multiple aa-tRNA
specificities. For instance, one of the two aaPGS paralogs found in Enterococcus faecium,
RakPGS, catalyzes the formation of Arg-PG, Ala-PG, and Lys-PG, while the function of the
second paralog in this organism has yet to be determined [9]. Further, more distant
homologs have been identified that exhibit activities quite different from what has been
characterized thus far. For example, a recent study found that the protein VlmA was unable
to aminoacylate any membrane lipids in Streptomyces viridifaciens. Instead, this protein
utilizes Ser-tRNASer to transfer Ser to an intermediate in the biosynthesis of the antibiotic
valanimycin [10]. A recent and ongoing project in our lab considered the genetic context of
aaPGS, particularly the potential functional associations between aaPGSs and other genes.
This analysis resulted in a distribution of 3 types of putative esterases found in synteny
with aaPGS homologs: 1) -hydrolases, which are found mainly in Gram-positive
organisms; 2) VirJ-like proteins, which are mainly found in Gram-negative organisms; and
3) esterases, which are found in cyanobacteria and actinobacteria (Table 1). Two of these
4

Table 1: Phylogenetic distribution of conserved protein families found in synteny with aaPGS genes. The genomic
context of 605 aaPGS genes from 293 bacterial species was analyzed, and the percentage of occurrence of each family of
proteins (located adjacent to aaPGS) is shown for each family of proteins. When more than one protein family was found
in symteny with sa single aaPGS gene in one or more species, the sum of percentages is >100. Adapted from [7]

Protein families (Pfam)
Bacterial groups

α/β-Hydrolase Esterase VirJ No ORFb

a

%

%

%

%

18

32

0

51

25

0

0

75

Bacillales (61)

0

0

0

100

Clostridia (28)

43

0

0

57

Lactobacillales (59)

42

0

0

58

Enterococcus (28)

100

0

0

0

Lactobacillus (25)

0

0

0

100

Lactococcus (17)

53

0

0

47

Leuconostoc (6)

100

0

0

0

12

61

0

30

5

2

53

42

Bacteroidetes (6)

0

0

67

33

Chloroflexi (3)

0

0

0

100

Cyanobacteria (6)

33

67

0

33

Fusobacteria (4)

0

0

0

100

Proteobacteria (158)

4

0

61

37

α (73)

1

0

45

53

β (27)

0

0

96

4

δ (11)

25

0

50

45

γ (47)

4

0

68

30

Gram-positive (306)
Firmicutes (147)

Actinobacteria (159)
Gram-negative (187)
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putative hydrolytic enzymes, PA0919 from P. aeruginosa, and AhyD from E. faecium,
representing the VirJ proteins and the α/β-hydrolase class of enzymes, respectively, were
recently the focus of independent functional studies ([11] and [7], respectively). Both of
these proteins were shown to exhibit aa-PG hydrolytic activity, and to modulate overall
levels of aa-PG in the bacterial membrane, providing optimal resistance to antibiotics and
other stress conditions. Until recently, the function of the third type of
hydrolytic enzyme, the esterases, which are often found in synteny with type VII aaPGS
homologs in Actinobacteria, had yet to be determined [12].
Further analysis of this data revealed that aaPGS homologs can be grouped into 7
main types (I-VII), based on their phylogenetic origin and structures. Type I and type III
enzymes are found mostly in Proteobacteria, type II are found in Firmicutes, type IV and
type VII are found in Actinobacteria, and type VI are found in Actinobacteria and some
Proteobacteria. These structural types can also be correlated to data from recent functional
studies. Types I, II, and IV were independently investigated, and found to be specific for the
transfer of either Ala [6] or Lys (type I); only Lys (type IV) [3]; or Arg, Lys, and Ala (type II)
[9]. Type VI homologs include the VlmA protein responsible for the transfer of Ser to an
intermediate in the biosynthesis of the antibiotic valanimycin [10]. Currently, there is no
functional data for types III, V, and VII. This, in addition to the unique activity of VlmA (a
type VI), suggests that the more distantly related homologs may have distinct functions
other than transferring aa to PG. Furthermore, a single organism may harbor several aaPGS
homologs, or paralogs, which generally arise due to a gene duplication event in which a
second gene acquires a unique, but mechanistically related function [13]. Several paralogs,
6

particularly those found in actinobacteria, are classified as different types according to our
analysis, also suggesting different functions.
This prompted our investigation of one of the aaPGS paralogs (a type VII enzyme)
found in Corynebacterium glutamicum, which also harbors a conserved, putative esterase
found directly adjacent and upstream of aaPGS. In fact, a new lipid aminoacylation pathway
was identified, which results in the synthesis of Ala-PG, as well as a novel alanylated lipid,
Ala-diacylglycerol (Ala-DAG). While Ala-DAG formation in this organism was dependent on
the activity of the aaPGS homolog, synthesis of Ala-PG was dependent upon activity of the
same enzyme acting in concert with the putative esterase encoded directly upstream [12].
Although the project in its entirety is beyond the scope of the current document, this
work will include a description of the generation of in-frame, markerless aaPGS deletion
strains, as well as a complementation strategy used for investigating the role of the aaPGS
homolog (Cg1103), and putative esterase (PesT) in C. glutamicum (see Chpt II V.1).
Collectively, what is currently known about aaPGSs indicates that these proteins
belong to a diverse family of tRNA-dependent transferases with variable substrate
specificities. In addition, the broad distribution of these virulence factors across bacterial
species makes them attractive targets for the design of novel therapeutic strategies. While
our recent work has provided a global perspective on the relationship between the
structure and function of aaPGSs, little is known about this relationship at the level of each
individual enzyme.

7

1.3. Structure-function relationship of aaPGSs
aaPGSs are comprised of a hydrophilic C-terminal domain (localized to the
cytoplasm), which harbors the catalytic site of the enzyme [9], and a hydrophobic Nterminal domain bearing flippase activity that translocates neosynthesized aa-PG from the
inner leaflet of the cytoplasmic membrane to the outer leaflet [14]. Despite differences in
the substrate specificities of the different enzymes, the C-terminus of all known aaPGS
homologs is relatively conserved [9]. In contrast, there is considerable structural variability
within the N-terminal membrane domain of aaPGSs, which harbors the enzyme’s flippase
activity. The size of this domain ranges from 6 to 14 transmembrane α-helices, and the
sequences of various proteins exhibit a low degree of conservation across species. Recent
studies in S. aureus revealed that the flippase activity of aaPGS is required for decreased
susceptibility to CAMPs [14]. In addition, the flippases of the aaPGS homologs in S. aureus
and C. perfringens lack substrate specificity and are able to translocate Ala-PG and Lys-PG
across the membrane [15].
Lipid flippases found in the biogenic membranes of bacteria are faced with the
challenge of translocating the polar headgroups of phospholipids through the hydrophobic
core of the membrane bilayer. Accumulating evidence suggests that this is facilitated by the
presence of a solvent exposed cavity or channel within the membrane that allows for
passage of the polar headgroups of the lipids, while the hydrocarbon portions remain
associated with the hydrophobic core of the bilayer [16] (and see [17] & [18] for review).
In recent years, a number of topological mapping approaches have been developed to
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identify solvent exposed residues within integral membrane proteins with the aim of
defining flippase active sites (for review see [19]).
aaPGSs have been identified as attractive drug targets due to their prevalence across
bacterial species, and their role in antimicrobial resistance phenotypes and pathogenicity.
However, there is no high-resolution structure currently available, and the mechanisms for
synthesis of aa-PG and translocation of the neosynthesized lipid through the membrane
(i.e., flipping) have yet to be elucidated. One objective of the current study is to determine
the membrane topology of the triple-specific RakPGS from E. faecium, which is increasingly
found to be the etiologic agent of antibiotic-resistant nosocomial infections. Elucidation of
the membrane topology will facilitate definition of the active site residues of the flippase
domain located in the N-terminus of the protein.

9

II. AIMS
The hydrophobic membrane domain of aaPGSs has been shown to be indispensible
for resistance to CAMPs; however, to date, there is no high-resolution structure available.
In addition, the mechanism for flipping neosynthesized aa-PG from the inner- to the outerleaflet of the cytoplasmic membrane has yet to be elucidated. Although there are a
multitude of algorithms available for obtaining a membrane topology prediction model,
they often produce conflicting models, which ultimately necessitates experimental
determination of membrane topology [16]. The objective of the current study is to develop
techniques for experimental determination of the membrane topology of RakPGS from E.
faecium. Once optimized, these techniques will allow for definition of essential residues in
the membrane-associated flippase domain of RakPGS. Such residues will serve as potential
targets for therapeutic strategies that would abolish flippase activity, and increase the
efficacy of CAMPs produced by innate host defenses, as well as antimicrobials administered
by clinicians. The aims of this project are as follows:

2.1. Develop a dual PhoLacZ reporter strategy to determine the general membrane topology
of RakPGS
A dual PhoLacZ reporter strategy was designed in E. coli KRX cells capable of alpha
complementation. Using this system, the localization of several aa residues in the integral
membrane domain of RakPGS was determined in vivo by screening a randomly truncated
library of RakPGS-PhoALacZ fusion proteins.
10

2.2. Define expression, blocking, and labeling conditions of targeted Cys substitutions in
RakPGS using the substituted cysteine accessibility method (SCAM)
Several technical issues of SCAM were assessed and resolved, ultimately leading to
the site-directed chemical labeling of the native C601 residue in RakPGS. This technique
will be used in the future to define the set of solvent exposed residues in the integral
membrane domain of RakPGS, which potentially constitute the active site of the RakPGS
flippase.

2.3. Generation of in-frame, markerless aaPGS deletion strains and complementation in
Corynebacterium glutamicum
A two-step allelic exchange technique was used to generate in-frame, markerless
deletion of the pesT/aaPGS ORF in C. glutamicum for use in phenotypic screening in the
presence of several antimicrobial compounds. Likewise, a complementation assay was
performed to replace the pesT/aaPGS ORF, and validate the associated phenotypes
observed in the knockout strains.

11

III. MATERIALS AND METHODS
3.1. Bacterial strains and growth conditions.
C. glutamicum (ATCC 13032) was obtained from the American Type Culture
Collection, and grown in BHI broth at 30 °C with aeration by shaking. Alternatively, cells
were grown on plates of the same medium containing 1.5% (w/v) agar and supplemented
with 25 mg L-1 of kanamycin, as needed. Electrocompetent cells of C. glutamicum were
prepared and used according to established methods. E. coli strains were stored at -80°C in
LB broth supplemented with 15% glycerol, and grown in/on media supplemented with 50
mg L-1 of kanamycin, as needed.
Dual-colorimetric media was generated by supplementing LB agar with 1mM IPTG,
0.1% (w/v) L-rhamnose, 5-bromo-4-chloro-3’-indolyphosphate (BCIP) (80 mg L-1), 6chloro-3-indolyl-β-D-galactopyranoside (Red-Gal) (100 mg L-1), and 80 mM K2HPO4.
Briefly, LB agar was prepared for 250 mL was brought to 230 mL prior to autoclaving.
Subsequently, the ingredients listed above were added prior to pouring 25 mL plates.

3.2. Cloning of phoAlacZα
Alkaline phosphatase (PhoA) and the alpha fragment of β-galactosidase (LacZα)
were cloned from the genomes of E. coli S17 strain (ATCC47055), and E. coli XL1B,
respectively, into the pET-33b expression vector harboring rakPGS from E. faecium. Briefly,
both phoA and lacZα were separately amplified, and the resulting amplicons were stitched
12

together by overlap extension during PCR. The flanking oligonucleotides used for stitching
also incorporated the endonuclease sites for BamHI and PstI. The resulting ~1.5kb
fragment was sequenced, and digested with BamHI and PstI. Likewise, a linker was
constructed onto the 3’-end of rakPGS in pET-33b, which also harbors sites specific for
BamHI and PstI in the multiple cloning site. Following digestion and de-phosphorylation of
pet33b-rakPGS, the phoAlacZα fragment was ligated into the construct. Insertion of the
phoAlacZα was preliminarily verified by digestion of the completed construct with BamHI
and PstI, followed by agarose gel electrophoresis. Finally the construct was sequenced with
various oligonucleotides to ensure that rakPGS and phoAlacZα were in-frame.

3.3. Transformation of E. coli XL1B and KRX Competent Cells
Transformation solutions were prepared by adding 60 L H2O and 20 l KCM (0.5 M
KCl, 0.15 M CaCl2, 0.25 M MgCl2) to 20 L of each ligation product. Competent cells (E. coli
strain XL1B or KRX) were thawed on ice, and 100 L were added to each transformation
solution. The cells were placed on ice for 20 min, followed by room temperature for 10
mins. 800 L LB (Lauria-Bertani) broth was added and the cells were allowed to recover at
37°C for 1 h with no agitation. Cells were plated on LB agar supplemented with 25 mg L-1 of
kanamycin. Twelve colonies exhibiting kanamycin resistance were selected and used for
isolation of plasmid DNA as needed.
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3.4. Exonuclease III digestion
The pet33b-rakPGS-phoAlacZα construct was designed with an in-frame linker at the
3’-end of rakPGS. Briefly, the stop codon was removed from the 3’-end of rakPGS, and an
XhoI site was inserted. The 3’-end of the linker included a site recognized by PstI, followed
by phoA (residues 22-472) and lacZ (residues 4-60). Flanking oligonucleotides used for
cloning of phoA and lacZ incorporated PstI and BamHI sites at the 5’-end of phoA, and the
3’-end of lacZ, respectively. This allowed for cloning of the phoA-lacZ fragment (~1.5 kb)
into pET-33b-rakPGS following digestion with BamHI and PstI. Transformants harboring
the construct were then verified by digestion with the same endonucleases, followed by
sequencing. A large-scale preparation of the pet33b-rakPGS-phoAlacZα construct was then
purified, and subsequently digested with XhoI and PstI. XhoI digestion results in a recessed
3’-hydroxyl end, which is recognized by Exonuclease III (ExoIII).
Prior to digestion with ExoIII, a quenching solution containing S1 nuclease was
prepared, which consisted of 40 mM NaOAC (pH 4.6), 330 mM NaCl, 2.6 mM ZnSO4, and
374 U S1 nuclease in 375 L. Prior to addition of ExoIII, the solution was incubated for 5
min at 37°C. Upon addition of ExoIII, 4 l aliquots were removed every 15 s, and placed in
12 L S1 solution, which remained on ice until all 26 aliquots of ExoIII digest were
removed. These were then allowed to incubate for 30 min at RT, and subsequently 1.6 L
TE (300 mM Tris-base pH 11.1, 50 mM EDTA) buffer was added. 5 L from every other
sample was then used for NcoI digestion to ensure ExoIII digestion had not proceeded past
rakPGS (see section 4.1.2). Following exclusion of samples in which ExoIII had digested
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past rakPGS, 2 L from 5 different samples was combined for ligation overnight with T4
ligase. The entire ligation was then used to transform competent E. coli KRX cells, which
were then plated on dual-colorimetric media (see section 2.2). Colonies exhibiting
coloration were then isolated, and plasmid DNA was purified and sent for sequencing (see
Fig. 2).
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Figure 2: Generation of a randomly truncated library of RakPGS-PhoLac fusion proteins using ExoIII and S1
nucleases. See text for details.
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3.5. Substituted cysteine accessibility method (SCAM)
RakPGS from E. faecium was cloned into the pET-33b vector, yielding pET-33brakPGS. Expression conditions of E. coli C41, and subsequently E. coli BL21 cells harboring
pET33b-rakPGS were analyzed by inducing RakPGS expression in previously described
auto-induction media [20], or by induction with 0.1 mM IPTG, for varied durations.
Following determination of optimal conditions of the entire SCAM procedure, subsequent
experiments were conducted as follows: E. coli BL21 cells harboring pET-33b-rakPGSC568A-C573A were grown overnight in 5 mL LB broth supplemented with Kan 50 mg L-1.
100 mL LB broth with Kan 50 mg L-1 was then inoculated with 1/100th v/v from the starter
culture. Expression of RakPGS was then induced upon addition of 0.1 mM IPTG when the
culture reached an OD600 = 0.4. Following 2 hr induction at 37°C, the OD600 was determined,
and the cells were harvested and washed once in PBS pH 6.8. To ensure that a standardized
amount of cells were treated in each experiment, the pellets were resuspended in a volume
of PBS normalized to give a cell density equal to 20 mOD/μL. 50 μL, or 1 OD of cells, was
taken from this suspension, the cells were pelleted, and the supernatant removed. The
pellets were then resuspended in 100 μL PBS pH 6.8, and toluene (1% v/v) was added to
one sample, which was briefly vortexed and allowed to incubate 5 min at RT. This sample
was then treated with NEM, and another was treated with MTSES, both at 10 mM final.
Following 1 hr incubation at RT, the blocking agents were removed by first diluting the
solution 10x with PBS pH 6.8 and pelleting the cells, followed by washing 1x in PBS pH 6.8.
The pellet was then resuspended in 50 μl lysis buffer (8 M urea, 2% w/v SDS, 2 mM EDTA,
brought to volume with PBS pH 6.8; then brought to pH 6.8 with HCl).
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For labeling un-blocked Cys with Mal-PEG 5000, 25 mM Mal-PEG in DMSO was
prepared, and then subjected to gel filtration to remove any contaminants of impurities.
Briefly, a gel filtration column was prepared by loading a 1 ml syringe with Sephadex G25
beads (in DMSO), and centrifuging 5 min at 1000xg. Following one spin to remove excess
DMSO, the Mal-PEG solution was added to the column, and centrifuged 5 min at 1000xg.
The purified Mal-PEG solution was then added to 3 of the samples (positive Mal-PEG
control, NEM-treated, and MTSES-treated) to give a final concentration of 1 mM. A negative
control was included that was not treated with either of the blocking reagents, or Mal-PEG.
The lysates were homogenized by gently pipetting up/down, avoiding bubbles, which can
produce an oxidizing environment that is detrimental to the reaction between the thiolate
anion on Cys and the double bond on maleimide. Following incubation at 35 min at RT, the
reaction was quenched upon addition of 2X loading buffer (8 M urea, 3% SDS, 50 mM TrisHCl pH 6.8, 10% glycerol, 6.44 mM Na2HPO4, 3.16 mM NaH2PO4, 1% -ME, 0.1%
bromothymol blue), and homogenization. The lysate was allowed to incubate for 30 min at
45°C, and each sample was then sonicated for 10s. 100 mOD cells from each sample (1-4)
were then loaded into an 8% polyacrylamide SDS gel, which was run at 200 V for 30 min at
RT.
3.6. Western transfer and immunoblotting
Following SDS-PAGE, samples were transferred onto nitrocellulose membrane
(Amersham Protran 0.45 μm) by first subjecting the membrane and the gel to a
discontinuous buffering system. Briefly, the SDS gel and one piece of blotting paper were
allowed to incubate for 5 min in buffer containing 60 mM Tris-HCl, 40 mM CAPS, 15%
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methanol; and the nitrocellulose membrane and corresponding blotting paper were briefly
soaked in buffer containing 10 mM CAPS, 10% methanol, pH 11.1 with NaOH. Transfer was
conducted in a BioRad Trans-blot Turbo semi-dry transfer machine for 15 min at constant
100 mΩ and limiting V. Following transfer, the membrane was blocked in 50 mL TBST
containing 5% milk powder, either 1 hr at RT or ON at 4°C. Hybridization of primary
antibody was then allowed in 20 TBST, 3% BSA, with 1/3000th volume Anti-His6
(GE24471001) for 1 hr at RT or ON at 4°C. The membrane was then washed 3x 5 min in
TBST, then 1x 10 min TBST. Conjugation of secondary antibody was allowed in 20 mL
TBST, 3% BSA, with 3/10,000th anti-mouse IgG-HRP (Promega) for 1 hr at RT. The
membrane was then washed 3x 5 min, and 1x 10 min in TBST. Detection of antibodies was
achieved with a previously described ECL solution.
3.7. Generation of in-frame, markerless deletion of cg1103 and pesT from the genome of
Corynebacterium glutamicum.
A classic two-step approach was used for allelic exchange by homologous
recombination to generate markerless inactivation of C. glutamicum genes using the suicide
vector pK19mobsacB [21]. Genomic DNA from C. glutamicum ATCC13032 was first isolated
and purified, and subsequently used as template for PCR. Upstream and downstream
regions flanking the genes of interest were amplified so that 80% of the ORFs would be
deleted (see below). PCR products were stitched together using overlap extension, and
these products were then ligated into the pK19mobsacB. In this was, pesT, cg1103, or both
genes were inactivated using the vectors pK19mobsacB-ΔpesT, pK19mobsacB-Δcg1103, or
pK19mobsacB-Δcg1103ΔpesT, respectively. pK19mobsacB harbors a kanamycin resistance
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cassette (kanR) and the counterselectable marker sacB, which is under the control of an E.
coli origin of replication. sacB codes for levansucrase from Bacillus subtilis, which utilizes
sucrose for the production of levan, a toxic glycopolymer. The pK19mobsacB constructs
were used to transform C. glutamicum, which was plated on media supplemented with Kan.
As pK19mobsacB is a suicide vector with no origin of replication, a single recombination
event allows transformants to grow on media in the presence of Kan due to integration of
the plasmid into the genome. Several clones were passaged BHI broth supplemented with
Kan for isolation of genomic DNA and subsequent screening by PCR to ensure integration
of the plasmid, and to ensure that no slow growing, Wt C. glutamicum contaminants were
present. A second recombination event was allowed by passaging twice in the absence of
antibiotics, before plating on BHI supplemented with 10% (w/v) sucrose. The resulting
colonies on the BHI + 10% sucrose plates were then replica plated onto BHI supplemented
with Kan. Clones in which the plasmid had been lost and the majority of the targeted gene
had been deleted were then identified as KanS SucR. To ensure that the plasmid had been
lost, genomic DNA from KanS SucR clones was isolated and used as template for screening
by PCR using flanking oligonucleotides to the upstream and downstream regions of the
targeted genes (Fig. 3). The ΔpesT, Δcg1103, Δcg1103ΔpesT strains were then used in
subsequent experiments to determine the MICs of various CAMPs and other types of
inhibitors.
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Figure 3: Two-step allelic exchange. A two-step allelic exchange strategy was used for in-frame, markerless deletion of
cg1103 or pesT in C.glutamicum, generating Δcg1103 and ΔpesT strains, respectively. A similar process was employed for
replacing the genes at the original loci (complementation), generating Δcg1103-c and ΔpesT-c strains. See text for
additional details.
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IV. RESULTS: PART I
4.1. Membrane topology of RakPGS using the PhoLac dual-reporter system
4.1.1. Fusion of PhoALacZα to full-length RakPGS
To determine the orientation and approximate localization of the transmembrane
helices constituting the membrane domain of RakPGS, a library of proteins containing a
fusion between the C-terminal end of RakPGS and the dual reporter PhoALacZα was
screened. This dual reporter system is comprised of alkaline phosphatase (PhoA) and the
α-fragment of β-galactosidase (LacZα), and is used to investigate the topology of membrane
proteins expressed in an E. coli strain capable of alpha complementation (described below).
E. coli KRX cells, which are a K12 derivative, were selected for this study. Due to deletions
in both genomic and episomal copies of lacZ, KRX cells are deficient in -galactosidase
activity. The partial deletion in the episomal copy of lacZ (lacZ M15) can be
complemented by addition of a plasmid-encoded -fragment of LacZ, rendering a fully
functional enzyme. In addition to this feature, KRX cells include the gene encoding T7
polymerase, which is under the control of the rhamnose promoter rhaPBAD. This promoter
is repressed by glucose, and activated by addition of rhamnose to the medium. Specifically,
two activators, RhaR and RhaS, positively control regulation of T7 polymerase expression
driven by rhaPBAD. Addition of rhamnose to the medium induces RhaR, which then binds
the promoter responsible for production of high levels of T7 RNA polymerase expression.
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Figure 4: RakPGS-PhoLac construct. The E. coli KRX strain includes a rhamnose-dependent promoter that activates expression of T7 RNA polymerase,
allowing for precise control over expression of recombinant proteins. In addition, partial genomic and episomal deletions of lacZ allow for complementation by
via expression of a plasmid-encoded α-fragment. See text for additional details.

23

(Promega, 2014) (Fig. 4). These features of the KRX strain allow for precise control over
expression of recombinant proteins. LacZ is active only in the cytoplasm, and PhoA is active
only in the periplasm, allowing the topological location of the C-terminal residues of
RakPGS to be determined by measuring the activities of the two reporters [22]. PhoA and
LacZ activities were assayed by plating transformants harboring the fusion proteins on
media containing BCIP and Red-Gal (see section 3.1.), which are the colorimetric substrates
of PhoA and LacZ, respectively. Colonies with red coloration due to high LacZ activity and
low PhoA activity indicate that the fusion point between RakPGS and the dual PhoALacZα
reporter is located in the cytoplasm. In contrast, colonies with blue coloration due to high
PhoA activity and low LacZ activity indicate that the fusion point is periplasmic (Fig. 4).
To test the effectiveness of the dual-reporter system, as well as the supplemented
media, competent E. coli KRX cells were transformed with the full-length pet33b-rakPGSphoAlacZα construct (Fig. 5B), and plated on LB agar supplemented with BCIP, Red-Gal,
rhamnose, and IPTG (see section 3.1.). An E. coli XL1B pUC19-lacZ strain, which was
previously constructed in our lab and exhibits LacZ activity, was used as a positive control
(not shown). E. coli KRX cells with no vector (Fig. 5C), as well as E. coli KRX cells
transformed with pet33b-rakPGS (Fig. 5A) were used as negative controls. The red
coloration observed on the plate inoculated with the positive control, as well as that
observed on the plate inoculated with E. coli KRX cells transformed with the pet33brakPGS-phoAlacZα construct, indicates successful fusion of RakPGS-PhoLac (Fig. 5B).
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A

B

C

Figure 5: Full-length RakPGS-PhoLac construct. (A) E. coli KRX cells were transformed with empty pET-33b vector, or
(B) the dual PhoLac reporter fused to the full-length RakPGS. KRX cells with no additional vector were included as a
negative control (C). See text for details.
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In addition, these results indicate that the C-terminal residue of RakPGS is located within
the cytoplasm. This contrasts the topological prediction model generated by the TOPCONS
algorithm (Fig. 6), which predicts periplasmic localization of the C-terminal residue of
RakPGS.
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Figure 6: Topological prediction model of RakPGS generated with the TOPCONS algorithm. The N- and C-terminal aa residues are predicted to have
cytoplasmic and extracellular localization, respectively. See text for additional details.

27

4.1.2. Generation of a truncated library of RakPGS-PhoALacZα fusion proteins
To generate a random library of truncated RakPGS-PhoLac chimeras, a large-scale
preparation of the pet33b-rakPGS-phoAlacZα construct was first purified, and
subsequently digested with XhoI and PstI. The cut-sites recognized by these endonucleases
were incorporated into the construct at the 3’-end of rakPGS (in the case of XhoI), or at the
5’-end of the phoAlacZα fragment (in the case of PstI). Digestion with XhoI results in a
recessed 3’-hydroxyl end, allowing the linearized construct to be digested with
Exonuclease III (ExoIII), which catalyzes the sequential excision of mononucleotides from
the 3´-hydroxyl termini of duplex DNA (New England Biolabs, 2015). Aliquots were
removed every 30s and placed into a solution containing S1 nuclease, which removes
single-stranded overhangs, resulting in a blunt-end which can then be ligated (see Fig. 2,
section 3.4.). This allows for the step-wise truncation of the construct over a short period of
time, which was verified by subjecting the resulting DNA to agarose gel electrophoresis
(Fig. 7).
rakPGS was cloned into pet33b using NcoI at the 5’-end, and there is an additional
NcoI site located ~500 bp downstream of rakPGS, making it possible to screen the ExoIIIdigested aliquots for the presence of rakPGS using NcoI (data not shown). This allowed for
the exclusion of aliquots in which the ExoIII digestion had proceeded through rakPGS
entirely. Groups of five aliquots containing rakPGS were then combined and ligated
overnight. The ligations were then used to transform competent E. coli KRX cells, which
were plated on the supplemented LB media.
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Mins

Figure 7: Truncated RakPGS constructs. Truncated RakPGS-PhoLac constructs were generated by treatment with
exonuclease III (ExoIII). Aliquots were removed every 30s for 26 mins and placed in a solution containing S1 nuclease to
generate blunt-ends that were subsequently ligated to the PhoLac dual reporter construct. See text for additional details.
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4.1.3. Membrane topology of RakPGS-PhoLacZ chimeric proteins
The localization of several aa residues was determined by isolating colonies
exhibiting red coloration, indicating high LacZ and low PhoA activity. This in turn indicated
cytoplasmic localization of the fusion point between RakPGS and PhoLacZ. Of particular
interest were colonies from later time points of ExoIII digestion that had been combined
for ligation, as there was a higher probability of RakPGS-PhoLacZ fusion points in the Nterminal membrane domain of RakPGS. The purified DNA from several of these colonies
was sequenced, which revealed the precise locations of the rakPGS-phoAlacZ fusions, and
hence, the localization of the C-terminal aa residues. Interestingly, the localization of
several of the aa residues differs from what was predicted by the TOPCONS algorithm (Fig.
8).
Throughout the course of this study, sufficient PhoA activity was not consistently
observed. This prompted reanalysis of the construct harboring the cloned phoA, which
revealed several missense mutations in the 5’ region of the gene. Such mutations explained
the aberrant activity of PhoA, while the expression of the gene encoding the α-fragment of
LacZ, located downstream, was unaffected. A new construct harboring a re-cloned phoA is
currently

being

generated

for
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use

in

future

experiments.
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Figure 8: Localization of amino acid residues in RakPGS-PhoLac chimeras. RakPGS-PhoLac chimeric proteins were generated as described in the text.
Colonies exhibiting red coloration were isolated, after which plasmid DNA was isolated and sequenced. aa residues in green corroborate the predicted
localization using the TOPCONS algorithm; those in red do not.
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4.2. Membrane topology of RakPGS using the substituted cysteine accessibility method
(SCAM)
4.2.1. Structure determination of polytopic membrane proteins using thiol-reactive
chemical probes
One of the methods often used in conjunction with dual-reporter strategies in
topology studies of membrane proteins is the substituted cysteine accessibility method, or
SCAM [16]. SCAM relies on the reactivity of specific chemical probes with Cys residues
introduced by site-directed mutagenesis in the protein of interest. First, a protein lacking
Cys is generated by substituting all native Cys residues in the wild-type protein with Ser or
Ala. Importantly, these substitutions must not disrupt proper folding or activity of the
modified protein. Then, using site-directed mutagenesis, targeted Cys substitutions are
introduced at individual positions selected for probing. Cells harboring a recombinant
protein are subjected to two subsequent steps (Fig. 10): (1) blocking of the single Cys
residue is carried out with thiol-reacting chemicals that either cross or do not cross the
membrane

(NEM

(N-ethylmaleimide)

or

MTSES

(sodium

(2-sulfonatoethyl)

methanethiosulfonate), respectively), and (2) treated cells are lysed and any remaining
unblocked Cys are labeled with Mal-PEG 5000. Labeling with Mal-PEG 5000 results in a size
increase of the protein, which can be visualized by immunoblotting. Consequently, a
cytoplasmic Cys will be blocked with NEM, and the protein will not show a mass increase
following treatment with Mal-PEG 5000. Similarly, a periplasmic Cys will be blocked by
NEM and MTSES, and will show no size increase following treatment with Mal-PEG 5000.

32

Figure 10: Localization of site-directed, single Cys insertions using SCAM. All native Cys are replaced with Ser or Ala,
generating a protein devoid of Cys. Using site-directed mutagenesis, a single aa residue of interest is then replaced by Cys.
The protein is expressed, and whole cells are treated with thiol-reactive blocking reagents that either cross (NEM) or do
not cross (MTSES) the cytoplasmic membrane. Subsequently, the cells are lysed and treated with the Cys-specific labeling
reagent, Mal-PEG, which will react with unblocked Cys. This results in a mass increase, which is observed as a shift on a
western blot.

buried Cys residue (i.e., with transmembrane localization), on the other hand, will not react
with either NEM or MTSES, and will instead be labeled by Mal-PEG 5000 and consequently
exhibit a shift on a western blot. In this way, the solvent accessibility and localization of
individual residues can be determined on either side of the cytoplasmic membrane. Of
particular interest are residues that show partial blockage by NEM and MTSES, indicative
of exposure to solvent on both sides of the membrane. Such residues may constitute a
solvent-exposed cavity that harbors the active site of the RakPGS flippase domain.
Investigation of RakPGS using SCAM proved to be a technically challenging task,
which is often the case with methodologies used for structure determination of polytopic
membrane proteins [23]. As such, several technical factors were evaluated, tested, and
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resolved, including RakPGS expression conditions, maleimide and sulfhydryl reaction
conditions (e.g., pH, time, concentration), and the use of Mal-PEG of varied molecular
weights. In addition, western transfer and blotting conditions were optimized. Each
technical issue was assessed and resolved in succession, ultimately leading to the sitedirected chemical labeling of one of the three native cysteines in RakPGS.

4.2.2. Evaluation of optimal RakPGS expression conditions for use in SCAM
The native RakPGS from E. faecium was first cloned into the E. coli expression vector
pET-33b, which harbors a kanamycin resistance cassette. For the purpose of
immunoblotting, the sequence coding for a His-tag was inserted at either the 5’-end or 3’end of the 2.6 kb rakPGS. The construct harboring the N-terminal His-tag (pET-33b-rakPGSNt-His6) was then used to transform the E. coli C41 expression strain (see section III).
Subsequently, the kinetics of RakPGS expression was analyzed following overnight (ON)
induction in auto-induction media (see section 3.5.), or following induction with either 0.1
mM IPTG, or in auto-induction media over several hours. The aforementioned expression
conditions were simultaneously conducted at either 30°C, or ambient RT (~22°C)(Fig. 11).
Similar, sufficient levels of RakPGS expression were observed in samples taken from the ON
auto-induction media, and in samples following 4 hr IPTG induction, both of which were
incubated at 30°C. Because auto-induction media can be inoculated and left to incubate ON,
and samples can then be harvested with minimal preparation, it was determined to be a
more efficient strategy for expression of RakPGS for use in SCAM.

34

Figure 11: RakPGS expression conditions. RakPGS expression was induced overnight in auto-induction media or with
0.1 mM IPTG. Ala-tRNA synthetase (AlaRS) was included as a relative size determinant and western transfer control.
RakPGS was visualized on two separate membranes following identical exposure time. See text for details.
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RakPGS was expected to exhibit a molecular mass of ~100 kDa, allowing the use of a
previously purified Ala-tRNA synthetase (96 kDa) sample, which included a His-tag, as a
relative mass determinant. However, RakPGS displayed a mass considerably lower than
100 kDa (between 50-60 kDa). Membrane proteins are considerably more hydrophobic
than soluble proteins found in the cytosol, and are known to bind more SDS as a result.
This, in turn, can result in faster migration in denaturing conditions; however, to ensure
that the apparent migration pattern was not due to proteolytic cleavage of the protein, the
migration pattern of RakPGS with a C-terminal His-tag (RakPGS-Ct-His6) was investigated.
Expression and subsequent immunoblotting revealed a migration pattern identical to
RakPGS-Nt-His6, indicating that the full-length protein was in fact present (Fig. 10).
Having determined optimal RakPGS expression conditions in E. coli C41, RakPGS
mutants were constructed in which different combinations of one or two of the three native
Cys were substituted with Ala. These mutants were then used to analyze the conditions of
labeling with Mal-PEG.
4.2.3. Optimal concentration of maleimide for reaction with sulfhydryl group on Cys
SCAM is dependent upon the reactivity of thiol-specific reagents with a single Cys
residue introduced at a targeted location, which is a function of the local biochemical
milieu. In polar environments, such as the solvent-exposed environment found on either
side of the cellular membrane, the thiol functional group found on Cys has a pKa ~9. In
contrast, in non-polar environments, such as that found in the hydrophobic core of the
membrane bilayer, the pKa is ~14 [24]. Maleimides are commonly used for SCAM because
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Figure 12: Migration of RakPGS harboring N- or C-terminal His-tag. RakPGS constructs harboring N- or C-terminal
His-tags were expressed, resulting in identical migration patterns. Several lanes between AlaRS and the RakPGS
constructs were removed in constructing the figure, as they contained protein that did not transfer to the membrane
efficiently. See text for details.
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they are essentially unreactive until the ionized cysteinyl thiolate is encountered, and a
water molecule is required as a proton acceptor for the reaction to occur [25]. These
factors serve as the chemical basis for SCAM, as the reactivity of the thiol group on Cys will
reflect the localized environment in which it is found [23]. Increasing the pH of the reaction
conditions should therefore favor the reaction (optimal pH 8.0-8.5) [23]; however, raising
the pH above 7.5 increases the likelihood of maleimides reacting with primary amines [26].
In addition to controlling the pH of the thiol modification reaction, the concentration and
time of the reaction must be empirically determined.
Addition of Mal-PEG and the resulting shift of the labeled protein on a western blot
are essential to the SCAM strategy. Therefore, following determination of optimal
conditions for expression of RakPGS, the conditions of labeling with Mal-PEG were
investigated. The optimal concentration of Mal-PEG 2000 was investigated first. Wt RakPGS
was expressed E. coli C41, as described above. The cells were washed once with PBS pH 7.5,
and 1 OD of cells was then resuspended in 50 μl lysis buffer (see section 3.6) pH 7.5. 4
different lysates were then treated for 1 hr with varied concentrations of Mal-PEG 2000,
giving final concentrations of 0.1 mM, 0.5 mM, 1.0 mM, and 5.0 mM. Treatment of the lysate
with 0.1 mM Mal-PEG resulted in no observable shift on the western blot, indicating
incomplete labeling of the 3 Cys in RakPGS (Fig. 13, lane 2). In contrast, treatment of the
sample with either 0.5 or 1.0 mM Mal-PEG resulted in an observable shift, indicating
sufficient labeling (Fig. 13, lanes 4 and 6, respectively). Treatment of the lysate with 5 mM
Mal-PEG resulted in a slightly shifted, diffuse band on the western blot. These results
indicate that treatment of RakPGS with 0.5-1.0 mM Mal-PEG 2000 for 1 hr is sufficient for
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the SCAM strategy; however, there are a number of Mal-PEG compounds available with
covalently attached PEG molecules of varied molecular mass (kDa), including Mal-PEG
2000, 5000, and 10,000. We hypothesized that using Mal-PEG with greater molecular mass
would result in a more robust shift on a western blot, and would therefore be worth
investigating.
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Figure 13: Optimization of Mal-PEG concentration. Cell lysates containing RakPGS were treated for 1hr with 0.1 mM,
0.5 mM, 1.0 mM, or 5 mM Mal-PEG 2000. Each concentration was tested in duplicate. The lanes containing the second set
of samples were removed in construction of the figure.
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4.2.4. Use of Mal-PEG of varied molecular mass for labeling of RakPGS
The efficiency of labeling a RakPGS mutant with two native Cys was tested using 0.5
mM Mal-PEG 2000 (2k), 5000 (5k), or 10,000 (10k) (kDa). Relative to the no Mal-PEG
control and the lane containing RakPGS treated with Mal-PEG 2k, a considerably more
robust shift was observed when RakPGS was labeled with Mal-PEG 5k (Fig. 14; lanes 1, 2,
and 3, respectively). Treating RakPGS with Mal-PEG 10k resulted in even slower migration;
however, the bands are diffuse and not as visible (Fig. 14, lane 4). Interestingly, in all of the
lanes treated with Mal-PEG, a significant band is observed with a relative migration
identical to the negative control, indicating partial labeling of RakPGS. This contrasts what
was observed in the initial labeling optimization experiments (See Fig. 13 above). Several
hypotheses may explain why RakPGS was partially labeled: 1) that perhaps the pH of the
Mal-PEG reaction was not well controlled and may not be reproducible from one labeling
experiment to the next; 2) aging of the Mal-PEG reagent could lead to various detrimental
products that may be responsible for the apparent absence of a shift following labeling of
RakPGS.

For example, the instability of Mal-PEG could lead to a decrease in the

concentration of active labeling agent, or the formation of low molecular weight species
that are still able to label the protein, but unable to induce a shift (i.e., maleimide deprived
of the PEG functional polymer); and 3) that the evident lack of reproducibility of the
labeling conditions determined above was perhaps due to suboptimal temperature or
duration of the labeling step, and/or concentration of the labeling agent, which may in fact
be unstable over time. This prompted us to reevaluate the conditions of labeling RakPGS
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with Mal-PEG. Specifically, we determined how temperature, duration, pH, concentration,
and purity of Mal-PEG affected the labeling reaction.
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Figure 14: Optimization of Mal-PEG with PEG polymers of variable molecular mass. RakPGS with two native Cys was
labeled with 0.5 mM Mal-PEG 2,000, 5,000, or 10,000 kDa. See text for details.
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4.2.5. Subjecting Mal-PEG to gel filtration and adjusting pH, temperature, and
duration of reaction results in efficient labeling of RakPGS
A RakPGS mutant with 1 native Cys remaining (C601) was generated and used to
test the efficiency of labeling with 0.5 mM Mal-PEG 5k that had been subjected to gel
filtration. Specifically, 20 mM Mal-PEG 5k in DMSO was passed through a column
containing Sephadex G25 beads (see section 3). Labeling with Mal-PEG was conducted in
lysis buffer with pH 7.5 or 6.8, and was allowed to incubate for varied durations at RT or
65°C (Fig. 15). Subjecting the Mal-PEG 5k solution to gel filtration (Sephadex G25 beads)
prior to incubating the reaction in lysis buffer at either pH 6.8 or 7.5 at RT for 0.5, 1, or 2 hr
resulted in complete labeling of RakPGS (Fig. 15A.). Incubating the reaction at 65°C for 0.5
or 1 hr also resulted in complete labeling however, incubating for 2 hr led to denaturation
and complete loss of the protein. In contrast, use of Mal-PEG 5k that had not been subjected
to gel filtration resulted in incomplete labeling of RakPGS, regardless of temperature or
duration (Fig. 15B). These results indicate that complete labeling of RakPGS is dependent
upon subjecting the Mal-PEG solution to gel filtration prior to labeling to eliminate Mal-PEG
species with smaller PEG polymers. In addition, incubating the Mal-PEG reaction in lysis
buffer with pH ranging from 6.8-7.5 results in complete labeling of RakPGS. The efficacy of
the thiol-specific blocking agents, NEM and MTSES, was then evaluated.
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Figure 15: Gel filtration and optimization of Mal-PEG labeling conditions. (A) Mal-PEG 5,000 subjected to gel filtration (Sephadex G25 beads), or not (B),
was used to label the native Cys (C601) at varied pH, temperature, and duration. See text for details.
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4.2.6. Efficacy of blocking RakPGS C601 with the thiol-specific reagents NEM and
MTSES
To test the efficacy of the thiol-specific blocking agents, NEM and MTSES, 1 OD of
cells expressing RakPGS was resuspended in lysis buffer and treated with either reagent
prior to labeling with Mal-PEG. Subsequently, Mal-PEG was added to a final concentration 5
mM to ensure any unblocked Cys would be labeled, and exhibit a shift on a western blot. In
fact, the samples treated with NEM and MTSES exhibited no shift following treatment with
Mal-PEG, indicating that C601 in RakPGS was completely blocked by the reagents (Fig. 16,
lanes 3 and 4, respectively). Having defined optimal Mal-PEG labeling conditions, as well as
the efficacy of the blocking reagents complete, the SCAM strategy was ready to be used for
determination of the topological location of C601 of RakPGS.
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Figure 16: NEM and MTSES reactivity. E.. coli cells expressing RakPGS were lysed and C601 was blocked with the thiolspecific reagents NEM or MTSES. Subsequently, RakPGS was treated with 5 mM Mal-PEG 5,000 kDa.
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4.2.7. E. coli C41 and C43 over-expressing membrane proteins produce intracellular
membrane structures.
SCAM was used with the objective of determining the localization of a single Cys
residue in RakPGS. RakPGS harbors 3 native Cys residues that are located within the
hydrophilic synthase domain, which is localized to the cellular cytoplasm [9]. Therefore,
results from SCAM on the RakPGS mutant harboring 1 native Cys (C601) were expected to
indicate cytoplasmic localization of this residue. Specifically, NEM, which crosses the
cytoplasmic membrane, was expected to block C601, resulting in no shift following
treatment with Mal-PEG. In contrast, MTSES, which does not cross the membrane, was not
expected to block C601, which would then result in a shift following Mal-PEG treatment.
Several attempts were made, and a shift was observed in the lanes containing samples
treated with either NEM or MTSES prior to labeling with Mal-PEG (Fig. 17, lanes 3 and 4,
respectively). These results indicated that C601 was not accessible to either of the thiolreactive reagents, NEM or MTSES, implying that this residue was located within a
transmembrane helix. This led to re-investigation of the E. coli expression strain C41, which
is commonly used to over-express proteins. In fact, over-expression of membrane proteins
in E. coli C41 and C43 has been shown to result in the formation of abundant intracellular
membrane structures [27] (See Fig. 18). While this is advantageous for protein purification
strategies, in which the protein of interest can be isolated from these structures with high
yield, the abundance of intracellular membrane structures renders E. coli C41 unusable for
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the SCAM procedure. As such, a different E. coli strain was selected for expression of
RakPGS and re-optimization of the SCAM procedure.
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Figure 17: SCAM on RakPGS C601. Several attempts were made to block and subsequently label RakPGS C601, each
resulting in partial labeling. See text for details.
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Figure 18: E. coli C41 intracellular membrane structures. Electron micrographs revealing abundant production of
intracellular membrane structures following overexpression of membrane proteins in the E. coli C41 strain. Adapted from
Arechaga et.al., 2000. See text for details.
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4.2.8. C601 of RakPGS determined to have cytoplasmic localization using SCAM
An E. coli BL21 strain harboring pET-33b-RakPGS-C568A-C573A was constructed,
and expression conditions of SCAM were re-optimized in this strain. It was determined that
IPTG induction for 4 hr resulted in sufficient expression of RakPGS for use in SCAM. To
ensure that the cytoplasmic membrane was permeable to NEM, toluene was added prior to
treatment of this sample (see section 3.5.). This strategy proved effective as much less of
the sample treated with toluene exhibited a shift on a western blot following treatment
with Mal-PEG, relative to the sample not treated with toluene (Fig. 19, compare lanes 3 and
4). In addition, only partial blocking of C601 with MTSES was observed. These results
indicate cytoplasmic localization of C601 in RakPGS, and that SCAM can be used in the
future to define the set of solvent exposed residues in the integral membrane domain of
RakPGS, which potentially constitute the active site of the RakPGS flippase.
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Figure 19: Cytoplasmic localization of the native C601 in RakPGS. The localization of the native C601 in RakPGS was
determined using SCAM. Whole cells were treated, or not, with 1% (v/v) toluene prior to treatment with NEM. See text for
details.
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V. RESULTS: PART II
5.1. cg1103 confers a fitness advantage to C. glutamicum grown in certain conditions of
stress
aa-PG synthesis has been linked to an increase in the minimum inhibitory
concentrations (MICs) of various antimicrobial compounds, including lipopeptides and
glycopeptides (e.g., daptomycin and vancomycin), certain cationic antimicrobial peptides
(CAMPs), and to some osmolytes such as lactic acid [6, 28] (for review see [2]). To
determine whether pesT or cg1103 provide an advantage for C. glutamicum grown in the
presence of some of these compounds, growth of the ΔpesT or Δcg1103 strains was
compared to that of the Wt C. glutamicum. Specifically, MICs of bacitracin (0.5 µg mL-1),
daptomycin (3.3 µg mL-1), nisin (20 µg mL-1), polymyxin B (1.6 µg mL-1), protamine sulfate
(40 µg mL-1), vancomycin (0.2 µg mL-1), and lactic acid (0.2 % v/v) were determined for the
Wt C. glutamicum and the ΔpesT or Δcg1103 strains. Importantly, in the absence of these
compounds, growth of C. glutamicum was not affected by the deletion of pesT or cg1103.
Among the compounds tested, only lactic acid, polymyxin B, and protamine sulfate had a
significantly higher inhibitory effect on the Δcg1103 strain than on Wt C. glutamicum.
Inhibition of growth of the Wt C. glutamicum and the Δcg1103 strain, in the presence of
lactic acid, is shown as an example (Fig. 20A), and the fitness of each strain (i.e., the μmax) is
plotted relative to variable concentrations of each of the three compounds (Fig. 20B).
Subsequently, the inhibited growth phenotype of the Δcg1103 strain was completely
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reverted back to wild-type levels in the complementation strain, Δcg1103-c, in which the
cg1103 gene was replaced in the genome at the original locus using the same two-step
allelic

exchange

strategy

as

described
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in

methods

(section

3.7.).

Figure 20: Growth kinetics of C. glutamicum subjected to various conditions of stress. (A) The growth maximum of Wt C. glutamicum and the cg1103
mutant was measured in the presence of varied percentages (v/v) of lactic acid. (B) The fitness of Wt C. glutamicum and cg1103 and pesT mutants was
measured in the presence of lactic acid, protamine sulfate, and polymyxin B. See text for details.
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VI. DISCUSSION
6.1. aaPGSs are a heterogeneous family of proteins that represent potential targets for
novel therapeutic strategies
aaPGSs are a heterogeneous family of enzymes responsible for lipid aminoacylation
in the cytoplasmic membranes of a wide range of bacteria. Modification of membrane lipids
by aaPGSs has been shown to confer resistance to CAMPs, as well as several classes of
antimicrobial agents and stress conditions. Over 600 homologs have been identified, which
are present in a number of clinically relevant microorganisms. The majority of the 23 that
have been characterized are responsible for transfer of Lys from Lys-tRNALys to membrane
PG; however, aaPGSs have been identified that are responsible for synthesis of Ala-PG and
Arg-PG. The variable substrate specificities of aaPGSs, along with their broad distribution
across bacterial species, makes them attractive targets for the development of novel
therapeutic strategies. However, there is currently no high-resolution crystal structure
available, and the little is known about the relationship between the function of aaPGSs and
their structure.
One of the objectives of the current project was to experimentally determine the
membrane topology of the aaPGS homolog from E. faecium, RakPGS. The membrane
domain of RakPGS, which was predicted to consist of 12 transmembrane helices by the
TOPCONS algorithm, is thought to harbor flippase activity that translocates neosynthesized
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aa-PG from the inner leaflet to the outer leaflet of the cytoplasmic membrane. The
translocation of aa-PG to the outer membrane has been shown to be essential for decreased
susceptibility to CAMPS [14], therefore the focus of the present study was the topology of
the membrane domain thought to be responsible for this activity. Two experimental
approaches were developed for mapping the topology of RakPGS in this study: 1) a dualreporter system consisting of alkaline phosphatase and -galactosidase, and 2) the
substituted cysteine accessibility method (SCAM). Both methods required extensive
development to set the foundation for obtaining a topology map of RakPGS experimentally.
In this project, both protocols were optimized and validated with pilot studies.

6.2 Membrane topology of RakPGS using the PhoLac dual-reporter strategy
The PhoLac dual-reporter strategy sought to determine the orientation of the
transmembrane α-helices constituting the integral membrane domain of RakPGS in vivo by
screening a random library of protein fusions harboring the dual enzymatic reporter
PhoALacZα. Design of the system in E. coli KRX cells appeared to be successful, as
evidenced by plating transformants on media supplemented with the two colorimetric
substrates of the enzymes resulting in a number of red colonies. This indicated cytoplasmic
fusion of the dual-reporter to RakPGS, and allowed for the experimental mapping a number
of aa residues. However, following several experiments, the expected blue coloration that
would indicate high alkaline phosphatase activity, and periplasmic localization of the
fusion, was ambiguous at best. The lack of unambiguous blue colonies led to the hypothesis
that PhoA was exhibiting only partial activity due to an issue present in the phoA sequence.
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Subsequent reanalysis of the phoA sequence that had been cloned into the pET-33b vector
resulted in the observation of several mis-sense mutations in the sequence encoding PhoA,
which corroborated this hypothesis. As the phoA sequence alone had been verified by
sequencing, we also hypothesized that the mutations were introduced during the stitching
by overlap extension PCR. Therefore, the genes encoding PhoA and LacZ are currently
being re-cloned into the pET-33b construct, with sequence verification each step. This will
ultimately result in sufficient PhoA activity for determination of periplasmic localization of
aa residues within RakPGS-PhoALacZ chimeras.
Identification of the mis-sense mutations in phoA explained the unaffected activity
of the LacZ, as the gene encoding the alpha fragment of LacZ was located downstream in
the construct. Sequencing of DNA isolated from several red colonies revealed the
localization of 15 residues, many of which conflicted with the localization predicted by the
TOPCONs algorithm. This is not surprising, as prediction models are often found to conflict
with experimentally obtained topological maps [16]. Using the results obtained from the
LacZ activity, a new topological map of RakPGS was constructed (Fig 21). This model
corroborates recent evidence obtained using site-directed fusions of either LacZα or PhoA
to the RakPGS homolog (MprF) in S. aureus [29]. Our model contains several residues that
exhibited LacZ activity, but are thought to be within transmembrane helices. Although
initially confounding, we hypothesize that the high LacZ activity of these fusion points was
due to the existence of a solvent-exposed cavity within the first 6 N-terminal
transmembrane helices of RakPGS. This region was found to be essential for flippase
activity in S. aureus [29], and a solvent-exposed cavity has been defined in the dedicated
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Figure 21:Experimental model of RakPGS. An experimental model of RakPGS was constructed using data obtained from RakPGS-PhoLac chimeras. Red stars
indicate amino acid residues that exhibited high b-galactosidase activity when fused to the PhoLac dual reporter. See text for additional details.
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lipid II flippase in E. coli, MurJ ([16] and [30]). The construction of a fully functional
PhoALacZ dual-reporter will facilitate further investigation of such a cavity in RakPGS.

6.3. Using SCAM, the native C601 of RakPGS was determined to be located within the
cytoplasm
SCAM is often used in conjunction with reporter strategies, and allows for a more
precise definition of the membrane topology of integral membrane proteins; however, this
method is inherently challenging for a number of reasons. Firstly, the targeted substitution
of aa residues throughout a protein with Cys may result in a decrease in protein expression
due to improper folding. In addition, introduction of Cys increases the possibility of
disulfide bridge formation between proteins, resulting in the formation of dimers and the
inaccessibility of the sulfhydryl group to chemical blocking agents essential to the
technique. Introduction of Cys into a transmembrane helix may also inhibit the ionization
of the thiol group on Cys, so results indicating intramembrane localization of the aa residue
must be considered with caution [23]. Further, targeted introduction of Cys can result in
changes in the local secondary structure, which in turn, may result in decreased
permeability of the membrane to blocking reagents such as NEM. Similarly, the local ionic
and electrostatic environment may affect the pKa of the thiol of the substituted Cys, in turn
causing a decrease in reactivity with blocking reagents [31]. In addition to these factors, the
conditions of expression, blocking, labeling, and western transfer must also be evaluated
and optimized. The interdependent nature of these factors dictates the evaluation of each
mutant generated for use in SCAM on an individual basis.
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One of the aims of the present study sought to use SCAM to corroborate results
generated using the dual-reporter system, and to define the set of solvent-exposed residues
in the RakPGS membrane domain that potentially constitute the flippase active site.
However, resolving the myriad technical issues inherent to the SCAM technique proved
time consuming, which dictated that the aim of defining solvent-exposed residues be
reduced to setting up the assay for future use in the lab. This was in fact accomplished, and
SCAM was used to experimentally determine cytoplasmic localization of the native C601
residue. As many of the technical issues inherent to SCAM were resolved during the course
of this project, the SCAM protocol will be used in future experiments to define the active
site of the RakPGS flippase, with minimal additional work expected.
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6.4. cg1103 provides C. glutamicum a fitness advantage in the presence of various
conditions of stress
Our investigation of the aaPGS homolog in C. glutamicum revealed that this enzyme,
AlaDAGS, provides increased fitness for this organism in the presence of lactic acid. This
result corroborates results of a recent study in Pseudomonas aeruginosa, in which Ala-PG
formation was shown to increase resistance to this osmolyte [6]. In addition, our results
show that alanylation of membrane lipids confers a moderate fitness advantage to C.
glutamicum grown in the presence of polymyxin B or protamine sulfate. This effect was
dependent on cg1103 alone, and not pesT, suggesting that formation of Ala-DAG is sufficient
to provide a fitness advantage against these compounds. Synthesis of aa-PG has been
identified as a common strategy used by bacteria to reduce the net negative charge of the
cytoplasmic membrane, thereby decreasing the affinity of positively charged antimicrobial
compounds [1, 6]. In addition, recent studies have shown that PG alanylation or lysylation
is correlated with resistance to protamine sulfate [4, 6] and polymyxin B [3, 32, 33], both of
which are CAMPs with broad-spectrum antibiotic activity affecting a wide range of
bacterial species. Hence, the observed Ala-DAG-dependent increase in fitness of C.
glutamicum grown in the presence of these CAMPs was not surprising, since Ala-DAG
formation is expected to result in alteration of the net charge of the cytoplasmic membrane
similar to formation of Ala-PG.
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